[{"id":"b14136e7-6351-43ad-b0f1-c1c1e7064e34","acronym":"","url":"https://clinicaltrials.gov/study/NCT06154551","created_at":"2023-12-04T19:35:35.804Z","updated_at":"2024-07-02T16:35:27.274Z","phase":"","brief_title":"Evaluation of the Levels of Salivary Paxillin Oral Premalignant and Malignant Lesions","source_id_and_acronym":"NCT06154551","lead_sponsor":"Cairo University","biomarkers":" PXN","pipe":"","alterations":" ","tags":["PXN"],"overall_status":"Completed","enrollment":" Enrollment 45","initiation":"Initiation: 11/29/2022","start_date":" 11/29/2022","primary_txt":" Primary completion: 06/20/2023","primary_completion_date":" 06/20/2023","study_txt":" Completion: 11/01/2023","study_completion_date":" 11/01/2023","last_update_posted":"2023-12-04"}]